UCBMC

China Spinal Cord Injury Network · Phase 1 active Biologic

At a glance

Generic name	UCBMC
Sponsor	China Spinal Cord Injury Network
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

UCBMC CI brief — competitive landscape report
UCBMC updates RSS · CI watch RSS
China Spinal Cord Injury Network portfolio CI